• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度人群精神分裂症中神经发育和神经免疫基因与抗精神病药物治疗反应的遗传关联评估。

Evaluation of genetic association of neurodevelopment and neuroimmunological genes with antipsychotic treatment response in schizophrenia in Indian populations.

作者信息

Jajodia Ajay, Kaur Harpreet, Kumari Kalpana, Kanojia Neha, Gupta Meenal, Baghel Ruchi, Sood Mamta, Jain Sanjeev, Chadda Rakesh K, Kukreti Ritushree

机构信息

Genomics and Molecular Medicine CSIR-Institute of Genomics and Integrative Biology Mall Road Delhi 110007 India.

Department of Psychiatry All India Institute of Medical Sciences Ansari Nagar New Delhi 110029 India.

出版信息

Mol Genet Genomic Med. 2015 Aug 9;4(1):18-27. doi: 10.1002/mgg3.169. eCollection 2016 Jan.

DOI:10.1002/mgg3.169
PMID:26788534
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4707035/
Abstract

Neurodevelopmental and neuroimmunological genes critically regulate antipsychotic treatment outcome. We report genetic associations of antipsychotic response in 742 schizophrenia patients from Indian populations of Indo-European and Dravidian ancestry, segregated by disease severity. Meta-analysis comparing the two populations identified CCL2 [rs4795893: OR (95% CI) = 1.79 (1.27-2.52), P = 7.62 × 10(-4); rs4586: OR (95% CI) = 1.74 (1.24-2.43), P = 1.13 × 10(-3)] and GRIA4 [rs2513265: OR (95% CI) = 0.53 (0.36-0.78), P = 1.44 × 10(-3)] in low severity group; and, ADCY2 [rs1544938: OR (95% CI) = 0.36 (0.19-0.65), P = 7.68 × 10(-4)] and NRG1 [rs13250975, OR (95% CI) = 0.42 (0.23-0.79), P = 6.81 × 10(-3); rs17716295, OR (95% CI) = 1.78 (1.15-2.75), P = 8.71 × 10(-3)] in high severity group, with incomplete response toward antipsychotics. To our knowledge, this is the first study to identify genetic polymorphisms associated with the efficacy of antipsychotic treatment of schizophrenia patients from two major India populations.

摘要

神经发育和神经免疫基因对精神分裂症治疗结果起着关键的调节作用。我们报告了来自印欧语系和达罗毗荼语系印度人群的742例精神分裂症患者抗精神病药物反应的基因关联,这些患者按疾病严重程度进行了分类。对这两个人群进行的荟萃分析发现,在低严重程度组中,CCL2基因(rs4795893:比值比[95%可信区间]=1.79[1.27 - 2.52],P = 7.62×10⁻⁴;rs4586:比值比[95%可信区间]=1.74[1.24 - 2.43],P = 1.13×10⁻³)和GRIA4基因(rs2513265:比值比[95%可信区间]=0.53[0.36 - 0.78],P = 1.44×10⁻³)与抗精神病药物反应有关;在高严重程度组中,ADCY2基因(rs1544938:比值比[95%可信区间]=0.36[0.19 - 0.65],P = 7.68×10⁻⁴)和NRG1基因(rs13250975,比值比[95%可信区间]=0.42[0.23 - 0.79],P = 6.81×10⁻³;rs17716295,比值比[95%可信区间]=1.78[1.15 - 2.75],P = 8.71×10⁻³)与对抗精神病药物反应不完全有关。据我们所知,这是第一项鉴定出与来自印度两大人群的精神分裂症患者抗精神病药物治疗疗效相关基因多态性的研究。

相似文献

1
Evaluation of genetic association of neurodevelopment and neuroimmunological genes with antipsychotic treatment response in schizophrenia in Indian populations.印度人群精神分裂症中神经发育和神经免疫基因与抗精神病药物治疗反应的遗传关联评估。
Mol Genet Genomic Med. 2015 Aug 9;4(1):18-27. doi: 10.1002/mgg3.169. eCollection 2016 Jan.
2
Frequency and correlates of antipsychotic polypharmacy among patients with schizophrenia in Denmark: A nation-wide pharmacoepidemiological study.丹麦精神分裂症患者中抗精神病药物联合使用的频率及相关因素:一项全国性药物流行病学研究。
Eur Neuropsychopharmacol. 2015 Oct;25(10):1669-76. doi: 10.1016/j.euroneuro.2015.04.027. Epub 2015 May 7.
3
Allelic variation in ApoC3, ApoA5 and LPL genes and first and second generation antipsychotic effects on serum lipids in patients with schizophrenia.载脂蛋白C3、载脂蛋白A5和脂蛋白脂肪酶基因的等位基因变异以及第一代和第二代抗精神病药物对精神分裂症患者血脂的影响。
Pharmacogenomics J. 2008 Jun;8(3):228-36. doi: 10.1038/sj.tpj.6500474. Epub 2007 Aug 28.
4
HTR2C polymorphisms, olanzapine-induced weight gain and antipsychotic-induced metabolic syndrome in schizophrenia patients: a meta-analysis.精神分裂症患者中5-羟色胺2C受体基因多态性、奥氮平引起的体重增加及抗精神病药物引起的代谢综合征:一项荟萃分析
Int J Psychiatry Clin Pract. 2014 Oct;18(4):229-42. doi: 10.3109/13651501.2014.957705. Epub 2014 Sep 18.
5
Role of ethnic variations in TNF-α and TNF-β polymorphisms and risk of breast cancer in India.印度 TNF-α 和 TNF-β 多态性的种族差异及其在乳腺癌风险中的作用。
Breast Cancer Res Treat. 2011 Apr;126(3):739-47. doi: 10.1007/s10549-010-1175-6. Epub 2010 Sep 28.
6
Evidence of association of serotonin transporter gene polymorphisms with schizophrenia in a South Indian population.南印度人群中血清素转运体基因多态性与精神分裂症关联的证据。
J Hum Genet. 2009 Sep;54(9):538-42. doi: 10.1038/jhg.2009.76. Epub 2009 Aug 28.
7
Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.精神分裂症的药物遗传学和药物基因组学:过去十年研究综述
Mol Psychiatry. 2007 Aug;12(8):707-47. doi: 10.1038/sj.mp.4002009. Epub 2007 Jun 5.
8
Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to antipsychotic treatment in patients with schizophrenia.GRIA1、GRIA2 和 GRIA4 多态性对精神分裂症患者诊断和抗精神病药物治疗反应的影响。
Neurosci Lett. 2012 Jan 6;506(1):170-4. doi: 10.1016/j.neulet.2011.10.074. Epub 2011 Nov 6.
9
Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment.儿茶酚-O-甲基转移酶(COMT)基因与精神分裂症及抗精神病药物治疗反应的关联研究。
Pharmacogenomics. 2009 Mar;10(3):385-97. doi: 10.2217/14622416.10.3.385.
10
Large-scale candidate gene study to identify genetic risk factors predictive of paliperidone treatment response in patients with schizophrenia.大规模候选基因研究以确定可预测精神分裂症患者帕利哌酮治疗反应的遗传风险因素。
Pharmacogenet Genomics. 2015 Apr;25(4):173-85. doi: 10.1097/FPC.0000000000000122.

引用本文的文献

1
Clinical Utility and Implementation of Pharmacogenomics for the Personalisation of Antipsychotic Treatments.用于抗精神病药物治疗个体化的药物基因组学的临床效用与实施
Pharmaceutics. 2024 Feb 7;16(2):244. doi: 10.3390/pharmaceutics16020244.
2
Fine-mapping of two differentiated thyroid carcinoma susceptibility loci at 2q35 and 8p12 in Europeans, Melanesians and Polynesians.欧洲人、美拉尼西亚人和波利尼西亚人中位于2q35和8p12的两个分化型甲状腺癌易感基因座的精细定位。
Oncotarget. 2021 Mar 2;12(5):493-506. doi: 10.18632/oncotarget.27888.
3
A novel canine reference genome resolves genomic architecture and uncovers transcript complexity.一个新的犬类参考基因组解决了基因组结构并揭示了转录复杂性。
Commun Biol. 2021 Feb 10;4(1):185. doi: 10.1038/s42003-021-01698-x.
4
Pharmacogenetics of Antipsychotic Drug Treatment: Update and Clinical Implications.抗精神病药物治疗的药物遗传学:更新与临床意义
Mol Neuropsychiatry. 2020 Apr;5(Suppl 1):1-26. doi: 10.1159/000492332. Epub 2018 Sep 26.
5
Integrated analysis of the critical region 5p15.3-p15.2 associated with cri-du-chat syndrome.与猫叫综合征相关的关键区域5p15.3 - p15.2的综合分析
Genet Mol Biol. 2019;42(1 suppl 1):186-196. doi: 10.1590/1678-4685-GMB-2018-0173. Epub 2019 Apr 11.
6
Genetic recovery of ErbB4 in adulthood partially restores brain functions in null mice.成年期 ErbB4 的遗传恢复部分恢复了缺失小鼠的大脑功能。
Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):13105-13110. doi: 10.1073/pnas.1811287115. Epub 2018 Nov 29.

本文引用的文献

1
Evidence for schizophrenia susceptibility alleles in the Indian population: An association of neurodevelopmental genes in case-control and familial samples.印度人群中精神分裂症易感等位基因的证据:病例对照和家系样本中神经发育基因的关联。
Schizophr Res. 2015 Mar;162(1-3):112-7. doi: 10.1016/j.schres.2014.12.031. Epub 2015 Jan 9.
2
Synergistic association of PI4KA and GRM3 genetic polymorphisms with poor antipsychotic response in south Indian schizophrenia patients with low severity of illness.PI4KA和GRM3基因多态性与病情严重程度较低的南印度精神分裂症患者抗精神病药物反应不佳的协同关联。
Am J Med Genet B Neuropsychiatr Genet. 2014 Dec;165B(8):635-46. doi: 10.1002/ajmg.b.32268. Epub 2014 Sep 11.
3
The glutamatergic aspects of schizophrenia molecular pathophysiology: role of the postsynaptic density, and implications for treatment.精神分裂症分子病理生理学的谷氨酸能方面:突触后密度的作用及其治疗意义。
Curr Neuropharmacol. 2014 May;12(3):219-38. doi: 10.2174/1570159X12666140324183406.
4
Genome-wide association study reveals two new risk loci for bipolar disorder.全基因组关联研究揭示了双相情感障碍的两个新风险位点。
Nat Commun. 2014 Mar 11;5:3339. doi: 10.1038/ncomms4339.
5
A pharmacogenetic study of risperidone on chemokine (C-C motif) ligand 2 (CCL2) in Chinese Han schizophrenia patients.利培酮对中国汉族精神分裂症患者趋化因子(C-C基序)配体2(CCL2)影响的药物遗传学研究。
Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jun 3;51:153-8. doi: 10.1016/j.pnpbp.2014.01.017. Epub 2014 Feb 2.
6
Genome-wide association study of bipolar disorder in Canadian and UK populations corroborates disease loci including SYNE1 and CSMD1.全基因组关联研究表明,加拿大和英国人群中的双相情感障碍与 SYNE1 和 CSMD1 等疾病位点相关。
BMC Med Genet. 2014 Jan 4;15:2. doi: 10.1186/1471-2350-15-2.
7
Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway.神经调节素-1 信号与抗精神病药物治疗:精神分裂症候选信号通路中的潜在治疗靶点。
Psychopharmacology (Berl). 2013 Mar;226(2):201-15. doi: 10.1007/s00213-013-3003-2. Epub 2013 Feb 7.
8
Exploring the pathogenetic association between schizophrenia and type 2 diabetes mellitus diseases based on pathway analysis.基于通路分析探讨精神分裂症与 2 型糖尿病的发病关联。
BMC Med Genomics. 2013;6 Suppl 1(Suppl 1):S17. doi: 10.1186/1755-8794-6-S1-S17. Epub 2013 Jan 23.
9
Genetic studies indicate a potential target 5-HTR(3B) for drug therapy in schizophrenia patients.基因研究表明,5-羟色胺受体3B(5-HTR(3B))是精神分裂症患者药物治疗的一个潜在靶点。
Am J Med Genet B Neuropsychiatr Genet. 2012 Dec;159B(8):1006-8. doi: 10.1002/ajmg.b.32105. Epub 2012 Oct 17.
10
Neurodevelopment and inflammatory patterns in schizophrenia in relation to pathophysiology.精神分裂症的神经发育和炎症模式与病理生理学的关系。
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Apr 5;42:63-70. doi: 10.1016/j.pnpbp.2012.08.015. Epub 2012 Sep 25.